Alexandre Mebazaa, MD, PhD Department of Anaesthesiology, Burn and Critical Care, Saint Louis-Lariboisière University Hospitals, AP-HP, Paris, France
Co-author of the European Society of Cardiology guidelines for acute heart failure Principal investigator in numerous clinical trials in heart failure
Pr Adriaan Voors
MD, PhD
Pr Adriaan Voors
MD, PhD
Adriaan Voors is Professor of Cardiology and specializes in heart failure. Currently, Professor Voors is Director of the Heart Failure Clinic of the Department of Cardiology of the University Medical Center Groningen. Professor Voors supervised 44 PhD students, mainly on heart failure related topics. He is an editorial board member of the European Journal of Heart Failure, Clinical Research in Cardiology, Cardiovascular Drugs and Therapy, the Journal of Cardiovascular Medicine, and Heart Failure Reviews. He is/was involved as principal investigator/executive/steering committee member of 49 clinical trials on novel therapies in acute and chronic heart failure. Prof. Voors was the co-chair of the 2016 ESC Heart Failure Guidelines. He has (co-) authored 690 peer-reviewed papers and several books and chapters, his Hirsch-index is 97.
Jeffrey Testani
MD
Jeffrey Testani
MD
Jeffrey Testani is an associate professor of Medicine and director of Heart Failure Research at Yale University. He is trained as an advanced heart failure and cardiac transplantation cardiologist. Dr. Testani runs a large research program focusing on cardio-renal interactions and diuretic resistance in heart failure.
Williams Evans
PhD
Williams Evans
PhD
William J. Evans, PhD is an Adjunct Professor of Medicine in the Division of Geriatrics at the Duke University Medical Center and Human Nutrition in the Department of Nutritional Sciences at the University of California, Berkeley. He previously was Vice President and head of the Muscle Metabolism Discovery Unit at GSK. With an H-index of 129 and more than 82,000 citations he is the author or co-author of more than 350 publications in scientific journals and was the first to describe sarcopenia. He is the co-inventor of the D3Creatine dilution method, a non-invasive and accurate measurement of muscle mass which is strongly related to health outcomes in older people. His work has been featured in the PBS series, NOVA, Good Morning America, 20/20, CBS evening news, CNN, and the New York Times. Dr. Evans has been invited to testify before the US Senate Select Committee on Aging on strategies to save Medicare. He is a founding member of the Society for Sarcopenia, Cachexia, and Wasting Disorders and recently received the Lifetime Achievement Award from the International Conference on Frailty and Sarcopenia Research.
Pr Alexandre Mebazaa
MD, PhD
Alexandre Mebazaa, MD, PhD Department of Anaesthesiology, Burn and Critical Care, Saint Louis-Lariboisière University Hospitals, AP-HP, Paris, France
Co-author of the European Society of Cardiology guidelines for acute heart failure Principal investigator in numerous clinical trials in heart failure